REGN—This current study is something of a hybrid - there were monthly appointments and scans, and treatments when needed.
In the real world, Lucentis patients see the eye doctor when they get treated—rarely, if ever, between treatments, as REGN alleges. I’m surprised that you’re falling for REGN’s spin that Trap is significantly more convenient than Lucentis. In fact, after the initial loading period, there is essentially no difference between the two drugs in convenience.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.